Inventor · disambiguated record
Michael J. Tolentino
Also filed as: TOLENTINO MICHAEL · TOLENTINO MICHAEL J · TOLENTINO MICHAEL JOTHAM
15 granted patents·10 pending applications·445 citations·filing 2002–2022
95Inventor score
Files withUNIV PENNSYLVANIA15REICH SAMUEL JOTHAM4REICH SAMUEL J2TOLENTINO MICHAEL J2AVICEDA OPHTHALMICS INC1
Top patents by PatentIndex Score
25 records- 0198US7674895B2Compositions and methods for siRNA inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2006·Granted Mar 9, 2010·131 cites·18 claims
- 0298US7345027B2Compositions and methods for siRNA inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2006·Granted Mar 18, 2008·85 cites·67 claims
- 0397US7148342B2Compositions and methods for sirna inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2002·Granted Dec 12, 2006·111 cites·15 claims
- 0494US7521431B2Compositions and methods for siRNA inhibition of HIF-1 alphaUNIV PENNSYLVANIA·Filed 2003·Granted Apr 21, 2009·58 cites·39 claims
- 0593US7750143B2Compositions and methods for siRNA inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2006·Granted Jul 6, 2010·15 cites·36 claims
- 0688US8546345B2Compositions and methods for siRNA inhibition of angiogenesisTOLENTINO MICHAEL J·Filed 2006·Granted Oct 1, 2013·8 cites·72 claims
- 0785US8193163B2Compositions and methods for siRNA inhibition of ICAM-1REICH SAMUEL J·Filed 2010·Granted Jun 5, 2012·9 cites·77 claims
- 0885US7847090B2Compositions and methods for siRNA inhibition of ICAM-1UNIV PENNSYLVANIA·Filed 2008·Granted Dec 7, 2010·5 cites·38 claims
- 0985US7645744B2Compositions and methods for siRNA inhibition of HIF-1 alphaUNIV PENNSYLVANIA·Filed 2009·Granted Jan 12, 2010·5 cites·31 claims
- 1083US8541384B2Compositions and methods for siRNA inhibition of angiogenesisTOLENTINO MICHAEL J·Filed 2006·Granted Sep 24, 2013·4 cites·19 claims
- 1182US9150863B2Compositions and methods for siRNA inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2014·Granted Oct 6, 2015·2 cites·20 claims
- 1281US8946403B2Compositions and methods for siRNA inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2013·Granted Feb 3, 2015·2 cites·10 claims
- 1379US8236775B2Compositions and methods for siRNA inhibition of HIF-1 αREICH SAMUEL JOTHAM·Filed 2009·Granted Aug 7, 2012·5 cites·77 claims
- 1472US2010168207A1Compositions and methods for sirna inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2009·Application pending·0 cites
- 1569US7807814B2Compositions and methods for combined therapy of diseaseUNIV PENNSYLVANIA·Filed 2004·Granted Oct 5, 2010·3 cites·4 claims
- 1669US2009104259A1Compositions and methods for sirna inhibition of angiogenesisUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 1767US7994305B2Compositions and methods for siRNA inhibition of angiopoietin 1 and 2 and their receptor Tie2UNIV PENNSYLVANIA·Filed 2004·Granted Aug 9, 2011·2 cites·59 claims
- 1867US2008188437A1Compositions and Methods for siRNA Inhibition of AngiogenesisUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 1959US2025195689A1Glycomimetic ligandsAVICEDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2056US2004220129A1Compositions and methods for siRNA inhibition of ICAM-1UNIV PENNSYLVANIA·Filed 2004·Application pending·0 cites
- 2152US2012276192A1Compositions and methods for sirna inhibition of icam-1REICH SAMUEL JOTHAM·Filed 2012·Application pending·0 cites
- 2252US2012308645A1Compositions and methods for sirna inhibition of hif-1 alphaREICH SAMUEL JOTHAM·Filed 2012·Application pending·0 cites
- 2351US2025186609A1Sialic-acid ligand decorated therapeuticsAVICEDA OPHTHALMICS INC·Filed 2021·Application pending·0 cites
- 2442US2012039986A1Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2REICH SAMUEL JOTHAM·Filed 2011·Application pending·0 cites
- 2540US2011300125A1Compositions and methods for combined therapy of diseaseREICH SAMUEL J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael J. Tolentino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →